Skip to main content

Xacduro

Generic: sulbactam and durlobactam

Verified·Apr 23, 2026
Manufacturer
Innoviva
NDC
68547-111
RxCUI
2665012
ICD-10 indication
J15.6

Affordability Check

How much will you actually pay for Xacduro?

In 30 seconds, see every legitimate way to afford Xacduro — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Xacduro

What is this medication?

Xacduro is a prescription medicine composed of two active ingredients, sulbactam and durlobactam, which work together to treat severe lung infections. It is specifically indicated for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia in adults. This medication is targeted toward infections caused by susceptible strains of a group of bacteria known as the Acinetobacter baumannii-calcoaceticus complex.

Healthcare professionals administer this medication through an intravenous infusion, usually in a hospital environment. Because it is designed to fight specific types of resistant bacteria, it is typically reserved for patients who have limited treatment options. Before or during administration, doctors will perform diagnostic tests to ensure that the bacteria causing the pneumonia are sensitive to this specific combination of drugs.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.